Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry
Open Access
- 12 October 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 5 (41), 26402-26412
- https://doi.org/10.1021/acsomega.0c02600
Abstract
Background: Esophageal squamous cell carcinoma (ESCC) is one of the most common malignancies with poor diagnosis. Esophageal squamous dysplasia (ESD) is considered as an immediate precancerous lesion of ESCC. Lack of biomarkers for discriminating ESCC and ESD from healthy subjects limits the early diagnosis and treatment of ESCC. Therefore, a serum metabolomic strategy was conducted to identify and validate potential metabolic markers for the screening of ESCC and ESD subjects. Methods: A total of 74 patients with ESCC, 72 patients with ESD, and 75 normal control (NC) subjects were enrolled in this study. Gas chromatography-mass spectrometry was used to acquire serum metabolic profiles. Pathway analysis was conducted to uncover the fluctuated metabolic pathways during ESCC. Multivariate analyses were used to screen and validate the biomarkers. Results: ESCC, ESD, and NC subjects revealed progressively altered metabolic profiles, in which amino acids globally increased, while fatty acids decreased in ESCCs compared with the control groups. Pathway analysis demonstrated the activated biosynthesis of amino acids and inhibited desaturation of saturated fatty acids. The panel constructed with propanoic acid, linoleic acid, glycerol-3-phosphate, and l-glutamine showed the area under the curve (AUC), sensitivity, and specificity of 0.817, 0.75, and 0.74, respectively, in the discrimination of ESCC/ESD patients from NC subjects. The panel constructed by propanoic acid, l-leucine, and hydroxyproline revealed the AUC, sensitivity, and specificity of 0.819, 0.76, and 0.72, respectively, in the discrimination of ESD from NC subjects. The combination of hypoxanthine, 2-ketoisocaproic acid, l-glutamate, and l-aspartate showed the AUC, sensitivity, and specificity of 0.818, 0.83, and 0.74, respectively, in the discrimination of ESCC patients from ESD subjects. Conclusions: Our study revealed the systematic landscape for metabolic alterations in sera of ESD and ESCC patients. The defined metabolite markers showed reasonable performance in the discrimination of ESCC and ESD patients, and may provide helpful reference for clinicians and biologists.Funding Information
- Ministry of Science and Technology of the People's Republic of China (2019YFC1605100)
- National Natural Science Foundation of China (21876169, 21934006)
This publication has 42 references indexed in Scilit:
- Interpretation of type 2 diabetes mellitus relevant GC-MS metabolomics fingerprints by using random forestsAnalytical Methods, 2013
- Global and Targeted Metabolomics of Esophageal Squamous Cell Carcinoma Discovers Potential Diagnostic and Therapeutic BiomarkersMolecular & Cellular Proteomics, 2013
- Proteomic Profiling of Breast Tissue Collagens and Site-specific Characterization of Hydroxyproline Residues of Collagen Alpha-1-(I)Journal of Proteome Research, 2012
- Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's diseaseNeurobiology of Aging, 2012
- Revealing the metabonomic variation of EC using 1H-NMR spectroscopy and its association with the clinicopathological characteristicsMolecular Biology Reports, 2012
- Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometryJournal of Chromatography B, 2009
- Serum Metabolite Profiling of Human Colorectal Cancer Using GC−TOFMS and UPLC−QTOFMSJournal of Proteome Research, 2009
- A consensus yeast metabolic network reconstruction obtained from a community approach to systems biologyNature Biotechnology, 2008
- Gas chromatography/flame ionisation detection mass spectrometry for the detection of endogenous urine metabolites for metabonomic studies and its use as a complementary tool to nuclear magnetic resonance spectroscopyRapid Communications in Mass Spectrometry, 2006
- Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk populationGut, 2005